Last updated on October 2018

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)


Brief description of study

The purpose of this multi-center event-driven study in non-dialysis (ND) participants with anemia associated with chronic kidney disease (CKD) is to evaluate the safety and efficacy of daprodustat compared to darbepoetin alfa.

Clinical Study Identifier: NCT02876835

Contact Investigators or Research Sites near you

Start Over

US GSK Clinical Trials Call ...

GSK Investigational Site
Flushing, NY United States
2.48miles
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Ridgewood, NY United States
2.88miles
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Laurelton, NY United States
6.26miles
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
New York, NY United States
6.63miles
  Connect »

US GSK Clinical Trials Call ...

GSK Investigational Site
Brooklyn, NY United States
6.79miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.